Sender Herschorn

7.3k total citations · 2 hit papers
95 papers, 5.3k citations indexed

About

Sender Herschorn is a scholar working on Urology, Rheumatology and Epidemiology. According to data from OpenAlex, Sender Herschorn has authored 95 papers receiving a total of 5.3k indexed citations (citations by other indexed papers that have themselves been cited), including 71 papers in Urology, 54 papers in Rheumatology and 33 papers in Epidemiology. Recurrent topics in Sender Herschorn's work include Urinary Bladder and Prostate Research (58 papers), Pelvic floor disorders treatments (50 papers) and Urinary Tract Infections Management (33 papers). Sender Herschorn is often cited by papers focused on Urinary Bladder and Prostate Research (58 papers), Pelvic floor disorders treatments (50 papers) and Urinary Tract Infections Management (33 papers). Sender Herschorn collaborates with scholars based in Canada, United States and United Kingdom. Sender Herschorn's co-authors include Paul Abrams, Debra E. Irwin, Zoë Kopp, Ian Milsom, Walter Artibani, Karin S. Coyne, K Reilly, Con Kelleher, Steinar Hunskaar and Christian Hampel and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The Journal of Urology.

In The Last Decade

Sender Herschorn

91 papers receiving 5.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Population-Based Survey of Urinary Incontinence, Overactive Bladder, and Other Lower Urinary Tract Symptoms in Five Countries: Results of the EPIC Study

2006 2.0k citations Debra E. Irwin, Ian Milsom et al. European Urology profile →
The International Continence Society (ICS) report on the terminology for adult male lower urinary tract and pelvic floor symptoms and dysfunction

2019 491 citations Sender Herschorn et al. Neurourology and Urodynamics profile →

Peers

Countries citing papers authored by Sender Herschorn

Since Specialization

Citations

This map shows the geographic impact of Sender Herschorn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sender Herschorn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sender Herschorn more than expected).

Fields of papers citing papers by Sender Herschorn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sender Herschorn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sender Herschorn. The network helps show where Sender Herschorn may publish in the future.

Co-authorship network of co-authors of Sender Herschorn

This figure shows the co-authorship network connecting the top 25 collaborators of Sender Herschorn. A scholar is included among the top collaborators of Sender Herschorn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sender Herschorn. Sender Herschorn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Safety and efficacy of an α₁‐blocker plus mirabegron compared with an α₁‐blocker plus antimuscarinic in men with lower urinary tract symptoms secondary to benign prostatic hyperplasia and overactive bladder: A systematic review and network meta‐analysis 2024 ·Neurourology and Urodynamics ·Sender Herschorn, Tufan Tarcan, Yuan‐Hong Jiang, Eric Chung, (unknown), Achim Steup, Budiwan Sumarsono	4
2	The Use of Metformin in Overactive Bladder: A Retrospective Nested Case-control, Population-based Analysis 2023 ·Urology ·(unknown), Rano Matta, Jennifer A. Locke, (unknown), Mina Tadrous, Refik Saskin, (unknown), Robert K. Nam, Sender Herschorn	2
3	Recurrent triamcinolone injections for the treatment of Hunner’s lesions in bladder pain syndrome 2022 ·Journal of Clinical Urology ·(unknown), Jennifer A. Locke, (unknown), Lesley K. Carr, Sender Herschorn	0
4	What are the chances of improvement or cure from overactive bladder? A pooled responder analysis of efficacy and treatment emergent adverse events following treatment with fesoterodine 2021 ·Neurourology and Urodynamics ·Adrian Wagg, Sender Herschorn, Martin Carlsson, (unknown), Matthias Oelke	6
5	Management of high-grade renal traumas with collecting system injuries 2021 ·Canadian Urological Association Journal ·Jennifer A. Locke, (unknown), (unknown), Andrea Phillips, Avery B. Nathens, Sender Herschorn, Ronald Kodama	2
6	Effect of mirabegron on cognitive function in elderly patients with overactive bladder: MoCA results from a phase 4 randomized, placebo-controlled study (PILLAR) 2020 ·BMC Geriatrics ·Tomas L. Griebling, Noll L. Campbell, Jeffrey Mangel, David Staskin, Sender Herschorn, (unknown), Carol R. Schermer	42
7	Mirabegron Vs Placebo Add-on Therapy in Men With Overactive Bladder Symptoms Receiving Tamsulosin for Underlying Benign Prostatic Hyperplasia: A Safety Analysis From the Randomized, Phase 4 PLUS Study 2020 ·Urology ·Sender Herschorn, Kevin T. McVary, (unknown), Steve Foley, Rita M. Kristy, Nurul Choudhury, John Hairston, Steven A. Kaplan	9
8	Patients’ perspective of telephone visits during the COVID-19 pandemic 2020 ·Canadian Urological Association Journal ·Jennifer A. Locke, Sender Herschorn, (unknown), Laurence Klotz, Ron Kodama, Lesley K. Carr	7
9	A Phase 4, double-blind, randomized, placebo-controlled, parallel group, multi-centre study to evaluate the efficacy, safety, and tolerability of mirabegron in older adult patients with overactive bladder syndrome (PILLAR) 2018 ·Neurourology and Urodynamics ·Adrian Wagg, David Staskin, Eli Engel, Sender Herschorn, Rita M. Kristy, Carol R. Schermer	1
10	Midurethral sling complications 2017 ·Canadian Urological Association Journal ·Sender Herschorn	3
11	Do Patient Characteristics Predict Responsiveness to Treatment of Overactive Bladder With Antimuscarinic Agents? 2014 ·Urology ·Sender Herschorn, Steven A. Kaplan, Franklin Sun, Fady Ntanios	16
12	Age-related efficacy of the selective ß3-adrenoceptor agonist mirabegron for the treatment of overactive bladder (OAB): pooled analysis of three prospective, randomised Phase III studies in patients aged >= 65 years 2012 ·Vikram Khullar, J. Cambronero, J.C. Angulo, Victor W. Νitti, Sender Herschorn, Philip Van Kerrebroeck, Mary Beth Blauwet, Caroline A. Dorrepaal, Emad Siddiqui, Nancy Martin	8
13	Efficacy of mirabegron in patients with overactive bladder (OAB): Pre-specified analysis of three randomised, double-blind, placebo-controlled, Phase III studies 2012 ·Neurourology and Urodynamics ·Victor W. Νitti, Sender Herschorn, Vikram Khullar, J. Cambronero, J.C. Angulo, Mary Beth Blauwet, Caroline A. Dorrepaal, Emad Siddiqui, Philip Van Kerrebroeck, Nancy Martin	4
14	EFFICACY OF BOTULINUM TOXIN A INJECTION FOR NEUROGENIC DETRUSOR OVERACTIVITY AND URINARY INCONTINENCE – A RANDOMIZED DOUBLE-BLIND TRIAL 2009 ·Neurourology and Urodynamics ·Sender Herschorn, Jerzy B. Gajewski, Karen Ethans, Jacques Corcos, Kevin Carlson, (unknown), (unknown), Luc Valiquette, Richard Baverstock, Sidney B. Radomski, Lesley K. Carr	2
15	Efficacy and Tolerability of Fesoterodine in Men With Overactive Bladder: A Pooled Analysis of 2 Phase III Studies 2009 ·Urology ·Sender Herschorn, J. Stephen Jones, Matthias Oelke, Scott MacDiarmid, Joseph T. Wang, Zhonghong Guan	35
16	Effects of tolterodine extended release on patient perception of bladder condition and overactive bladder symptoms 2008 ·Current Medical Research and Opinion ·Sender Herschorn, John Heesakkers, David Castro‐Díaz, Joseph T. Wang, Marina Brodsky, Zhonghong Guan, (unknown)	27
17	Examining lower urinary tract symptom constellations using cluster analysis 2008 ·British Journal of Urology ·Karin S. Coyne, Louis S. Matza, Zoë Kopp, Christine Thompson, David B. Henry, Debra E. Irwin, Walter Artibani, Sender Herschorn, Ian Milsom	27
18	S-Shaped Coaxial Dilators for Male Urethral Strictures 2007 ·Urology ·Sender Herschorn, (unknown)	11
19	Population-Based Survey of Urinary Incontinence, Overactive Bladder, and Other Lower Urinary Tract Symptoms in Five Countries: Results of the EPIC Study breakdown → 2006 ·European Urology ·Debra E. Irwin, Ian Milsom, Steinar Hunskaar, K Reilly, Zoë Kopp, Sender Herschorn, Karin S. Coyne, Con Kelleher, Christian Hampel, Walter Artibani, Paul Abrams	1988
20	Multicenter randomized clinical trial comparing surgery and collagen injections for treatment of female stress urinary incontinence 2005 ·Urology ·Jacques Corcos, Jean‐Paul Collet, Stanley H. Shapiro, Sender Herschorn, Sidney B. Radomski, E Schick, Jerzy B. Gajewski, Andrea Benedetti, (unknown), (unknown)	68

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact